Home > Drug Search >
  • company_query: Aridis Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (4) biology (24)
Status:
Approved (6) NDA Filing (1) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (11) Phase Ⅰ (6)
Clinical Stage:
Pending (3) Active (15) Discontinued (4)
Bio-Type:
Cell therapy (1) CAR T cell therapy (1) Vaccine (2) Recombinant enzyme (1) Recombinant cytokines (5) Recombinant hormone (1) Whole antibody (4)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (2) Amyotrophic lateral sclerosis (ALS) (1) Anemia (1) Breast cancer (3) Cystic fibrosis (CF) (1) Deep vein thrombosis (DVT) (1) Diabetic macular edema (1) Follicular lymphoma (1) HBV infection (1) HCV infection (2) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) Inflammatory bowel disease (1) Influenza virus infection (1) Pseudomonal infection (1) Graves ophthalmopathy (1) Melanoma (1) Multiple myeloma (MM) (3) Multiple sclerosis (MS) (2) Myelodysplastic syndrome (MDS) (1) Myeloid leukemia (1) Myocardial infarction (MI) (1) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (1) Pancreatic cancer (2) Pneumonia (1) Prostate cancer (1) Pulmonary embolism (1) Solid tumours (2) Type 2 diabetes (1) Colorectal cancer (2) Nosocomial Pneumonia (NP) (1) Autistic disorder (1) Type 1 diabetes (1) Neutropenia (2) Renal carcinoma (2) Autoimmune diseases (1) Ischemic stroke (1) Glioma (1) Plaque psoriasis (1) Diffuse large B cell lymphoma (1) Central nervous system disorders (1) Human papillomavirus infections (HPV) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top